SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurogen (NRGN)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
523 35 0 NRGN
Emcee:  Terry McCormick Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
273 Yeah, but.... I was the one that caught the fake. In 24 3/16, 3:59. Out thiscaram(o)uche-5/3/2000
272 Some serious negative tape-painting yesterday at the close (fake 3-point drop iThomas M.-5/3/2000
271 Proc Natl Acad Sci U S A 2000 Mar 28;97(7):3655-60 Distscaram(o)uche-4/7/2000
270 Tisch continue to accumulate NRGN while insiders bailed out (options) in a big Miljenko Zuanic-3/24/2000
269 NRGN is breaking out from a large base on good volume. The charts project to tThomas M.-3/9/2000
268 Tom: I'm out, sold last third at 46+ last week. Longer term I think there phbolton-3/6/2000
267biz.yahoo.com It's interesting that Mark Lampert (BVF Partners) was buying Thomas M.-3/6/2000
266 To NRGN executives and top management, It will be nice if You guys show bit moMiljenko Zuanic-3/5/2000
265 <<Neurogen has generated hits over the last five years in each of its druMiljenko Zuanic-2/23/2000
264 Tuesday February 22, 10:22 am Eastern Time Company Press Release SOURCE: Neurscaram(o)uche-2/22/2000
263 FWIW: Sold 2/3 late Friday. It just got to be too much money to have in one pophbolton-2/20/2000
262 Neurogen Announces Progress in Its Drug Development Programs to Treat Anxiety aphbolton-2/17/2000
261 FWIW: the all time closing high was 35.25 in March, 96. IMHO it seems that NRGphbolton-2/16/2000
260 Re: Oppenheimer They increased their position by about 300k shares since on aphbolton-2/13/2000
259 Hi Cubrilo, <<Kolko dugo ce ovo trajati, sve ide gore?>. Q: How longMiljenko Zuanic-2/12/2000
258 One more thing, For the start you can check their NEW web site. Finally they dMiljenko Zuanic-2/12/2000
257 Kolko dugo ce ovo trajati, sve ide gore? Zdravo. mcMichael M. Cubrilo-2/12/2000
256 <<I'm glad I am now looking at companies myself, rather than mutuals.Miljenko Zuanic-2/12/2000
255 Kind of OT, but doesn't seem odd that a Growth and Income fund would be sinJim Oravetz-2/12/2000
254edgar-online.com The Oppenheimer Global Growth & Income Fund takes a 10% slDoc Bones-2/12/2000
253 PB, There is nothing to be shame off. I also with interest read old article aMiljenko Zuanic-2/6/2000
252 Sure PB, even though the piece is ancient (<i>Pharmaceutical Executive, VPseudo Biologist-2/6/2000
251 Hey, fluff for those of you in Neurogen's backyard; not bad for the rest ofPseudo Biologist-2/6/2000
250 Fluff piece on Neurogen: pharmexec.com includes interview with CEO Pennerphbolton-2/6/2000
249 Neuroscience 2000;95(1):265-71 Distribution of galanin-1, -2 and -3 receptor scaram(o)uche-1/29/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News